References
- Larsson S O, Hedner U, Nilsson M. On coagulation and fibrinolysis in conservatively treated chronic uraemia. Acta Medica Scand 1971; 189: 433–441
- Livio M, Gotti E, Marchesi D, Mecca G, Remuzzi G, de Gaetano G. Uraemic bleeding: Role of anaemia and beneficial effect of red cell transfusion. Lancet 1982; ii: 1013–1015
- Castaldi P A, Rozenberg M C, Stewart J H. The bleeding disorder of uraemia: A qualitative platelet defect. Lancet 1966; ii: 66–69
- Remuzzi G, Benigni A, Dodesini P, et al. Platelet function in patients on haemodialysis. Depressed or enhanced?. Clin Nephrol 1981; 17: 60–63
- Gordge M P, Faint R W, Rylance P B, Neild G H. Platelet function and the bleeding time in progressive renal failure. Thromb Haemost 1988; 60: 83–87
- Moosa A, Greaves M, Brown C B, MacNeil S. Elevated platelet-free calcium in uraemia. Brit J Haematol 1990; 74: 300–305
- Remuzzi G, Benigni A, Dodesini P. Reduced platelet thromboxane formation in uraemia. Evidence for a functional cyclo-oxygenase defect. J Clin Invest 1983; 71: 762–768
- Bloom A, Greaves M, Preston F E, Brown C B. Evidence against a platelet cyclo-oxygenase defect in uraemic subjects on chronic haemodialysis. Brit J Haematol 1986; 62: 143–149
- Thorngren M, Shafi S, Born G V R. Thromboxane B2 in skin bleeding time blood and in clotted venous blood before and after administration of Acetylsalicylic Acid. Lancet 1983; i: 1075–1078
- Nossel H L, Yudelman I, Canfield R E, et al. Measurement of fibrinopeptide A in human blood. J Clin Invest 1974; 54: 43–53
- Reay P. Use of N-Bromosuccinimide for the iodination of proteins for radioimmunoassay. Ann Clin Biochem 1982; 19: 129–133
- Jackson C A, Greaves M, Patterson A D, Brown C B, Preston F E. Relationship between platelet aggregation, thromboxane synthesis and albumin concentration in nephrotic syndrome. Brit J Haematol 1982; 52: 69–77
- Jubelirer S J. Haemostatic abnormalities in renal disease. Am J Kidney Dis 1985; 5: 219–225
- Gordge M P, Faint R W, Rylance P B, Ireland H, Lane D A, Neild G H., Plasma D. Dimer A useful marker of fibrin breakdown in renal failure. Thromb Haemost 1989; 61: 522–525
- Moosa A, Greaves M, Brown C B. Products of fibrin degradation in uraemia. 1990, (Submitted for publication)
- Weiss H J, Lages B. Evidence of tissue factor dependent activation of the classic extrinsic coagulation mechanism in blood obtained from bleeding time wounds. Blood 1988; 71(3)629–635
- Remuzzi G, Livio M, Cavenaghi A E, Marchesi D, Mecca G, Donati M D, de Gaetano G. Unbalanced prostaglandin synthesis and plasma factors in uraemic bleeding: A hypothesis. Thromb Res 1978; 13: 531–536
- Kyrle P A, Stockenhuber F, Brenner B, et al. Evidence for an increased generation of prostacyclin in the microvasculature and an impairment of the platelet-granule release in chronic renal failure. Thromb Haemost 1988; 60: 205–208
- Moosa A, Greaves M, Brown C B B. Bleeding in renal failure. Lancet 1988; ii: 288–289
- Janson P A, Jubelirer S J, Weinstein M J, Deykin D. Treatment of the bleeding tendency in uraemia with cryoprecipitate. New Eng J Med 1980; 303: 1318–1322
- Mannucci P M, Remuzzi G, Pusineri F, Lombardi R, Valsecchi C, Mecca G, Zimmerman T S. Deamino-8-D-arginine vasopressin shortens the bleeding time in uraemia. New Eng J Med 1983; 308: 8–12
- Moosa A, Ball J, Greaves M. Plasma and Platelet von Willebrand factor defects in uraemia. Am J Med 1989; 87: 489–490
- Gerritsen S W, Akkerman J W N, Sixma J J. Correction of the bleeding time in patients with storage pool deficiency by infusion of cryoprecipitate. Brit J Haematol 1978; 40: 153–160
- Kobrinsky N L, Israels E D, Gerrard J M, et al. Shortening of bleeding time by l-deamino-8-D-arginine vasopressin in various bleeding disorders. Lancet 1984; i: 1145–1148